AstraZeneca's COVID-19 vaccine related woes grow

被引:0
作者
Satyanarayana, Megha
机构
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:11 / 11
页数:1
相关论文
共 50 条
  • [43] Oxford-AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign
    Vallee, A.
    Chan-Hew-Wai, A.
    Bonan, B.
    Lesprit, P.
    Parquin, F.
    Catherinot, E.
    Choucair, J.
    Billard, D.
    Amiel-Taieb, C.
    Camps, E.
    Cerf, C.
    Zucman, D.
    Fourn, E.
    PUBLIC HEALTH, 2021, 196 : 135 - 137
  • [44] Covid-19: AstraZeneca vaccine is approved in EU with no upper age limit
    Torjesen, Ingrid
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372 : n295
  • [46] Covid-19: Valneva's vaccine produces stronger immune response than AstraZeneca's, company reports
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 375 : n2551
  • [47] COVID-19 European countries pause AstraZeneca vaccine over side effects
    不详
    SCIENCE, 2021, 371 (6535) : 1186 - 1186
  • [49] Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic?
    Petersen, Michael Bang
    Jorgensen, Frederik
    Lindholt, Marie Fly
    VACCINE, 2022, 40 (04) : 558 - 561
  • [50] Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine?
    Cross, Samuel
    Rho, Yeanuk
    Reddy, Henna
    Pepperrell, Toby
    Rodgers, Florence
    Osborne, Rhiannon
    Eni-Olotu, Ayolola
    Banerjee, Rishi
    Wimmer, Sabrina
    Keestra, Sarai
    BMJ GLOBAL HEALTH, 2021, 6 (12):